These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 23811746)

  • 1. Effectiveness of Haemophilus influenzae type b vaccines administered according to various schedules: systematic review and meta-analysis of observational data.
    Jackson C; Mann A; Mangtani P; Fine P
    Pediatr Infect Dis J; 2013 Nov; 32(11):1261-9. PubMed ID: 23811746
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparing Haemophilus influenzae type b conjugate vaccine schedules: a systematic review and meta-analysis of vaccine trials.
    Low N; Redmond SM; Rutjes AW; Martínez-González NA; Egger M; di Nisio M; Scott P
    Pediatr Infect Dis J; 2013 Nov; 32(11):1245-56. PubMed ID: 24145955
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Modelling the effects of booster dose vaccination schedules and recommendations for public health immunization programs: the case of Haemophilus influenzae serotype b.
    Charania NA; Moghadas SM
    BMC Public Health; 2017 Sep; 17(1):705. PubMed ID: 28903749
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Haemophilus influenzae type b conjugate vaccines: considerations for vaccination schedules and implications for developing countries.
    Fitzwater SP; Watt JP; Levine OS; Santosham M
    Hum Vaccin; 2010 Oct; 6(10):810-8. PubMed ID: 20980793
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Conjugate vaccines for preventing Haemophilus influenzae type b infections.
    Swingler G; Fransman D; Hussey G
    Cochrane Database Syst Rev; 2003; (4):CD001729. PubMed ID: 14583937
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunological persistence in 5 y olds previously vaccinated with hexavalent DTPa-HBV-IPV/Hib at 3, 5, and 11 months of age.
    Silfverdal SA; Assudani D; Kuriyakose S; Van Der Meeren O
    Hum Vaccin Immunother; 2014; 10(10):2795-8. PubMed ID: 25483640
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of a Haemophilus influenzae type b-tetanus conjugate vaccine when administered separately or in combined vaccines for primary immunization in two consecutive national schedules in Turkey.
    Yüksel N; Beyazova U; Balci IF; Aksakal FN; Camurdan AD; Sahin F; Rota S
    Int J Infect Dis; 2012 May; 16(5):e354-7. PubMed ID: 22387144
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined Haemophilus Influenzae type B-Neisseria meningitidis serogroup C vaccine is immunogenic and well tolerated in preterm infants when coadministered with other routinely recommended vaccines.
    Omeñaca F; Arístegui J; Tejedor JC; Moreno-Perez D; Ruiz-Contreras J; Merino JM; Muro Brussi M; Sánchez-Tamayo T; Castro Fernandez J; Cabanillas L; Peddiraju K; Mesaros N; Miller JM
    Pediatr Infect Dis J; 2011 Nov; 30(11):e216-24. PubMed ID: 21747321
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effectiveness of Haemophilus influenzae type b Conjugate vaccine introduction into routine childhood immunization in Kenya.
    Cowgill KD; Ndiritu M; Nyiro J; Slack MP; Chiphatsi S; Ismail A; Kamau T; Mwangi I; English M; Newton CR; Feikin DR; Scott JA
    JAMA; 2006 Aug; 296(6):671-8. PubMed ID: 16896110
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.
    Allali S; Chalumeau M; Launay O; Ballas SK; de Montalembert M
    Cochrane Database Syst Rev; 2018 Aug; 8(8):CD011199. PubMed ID: 30125338
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Safety and immunogenocity of a novel combined Haemophilus influenzae type b-Neisseria meningitidis serogroups A and C-tetanus-toxoid conjugate vaccine in healthy Chinese children aged 6 months to 5 years old.
    Hu JL; Tao H; Li JX; Dai WM; Song B; Sun JF; Liu P; Tang J; Liu WY; Wang SY; Zhu FC
    Hum Vaccin Immunother; 2015; 11(5):1120-8. PubMed ID: 25833163
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Haemophilus influenzae type b (Hib) vaccine: an effective control strategy in India.
    Verma R; Khanna P; Chawla S; Bairwa M; Prinja S; Rajput M
    Hum Vaccin; 2011 Nov; 7(11):1158-60. PubMed ID: 22048118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effectiveness of conjugate Haemophilus influenzae type B vaccine in The Gambia 14 years after introduction.
    Howie SR; Oluwalana C; Secka O; Scott S; Ideh RC; Ebruke BE; Balloch A; Sambou S; Erskine J; Lowe Y; Corrah T; Adegbola RA
    Clin Infect Dis; 2013 Dec; 57(11):1527-34. PubMed ID: 24046305
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Conjugate Haemophilus influenzae type b vaccines for sickle cell disease.
    Allali S; Chalumeau M; Launay O; Ballas SK; de Montalembert M
    Cochrane Database Syst Rev; 2016 Feb; 2():CD011199. PubMed ID: 26881484
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).
    Dhillon S
    BioDrugs; 2010 Oct; 24(5):299-302. PubMed ID: 20795752
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Utilization pattern of Haemophilus influenza type b vaccine in eight provinces of China.
    Li Y; Yue C; Wang Y; Zhu X; Martin K; Scherpbier RW; Liu J; Wang Z; Ma Y; Cheng H; Zhang Z; Wang Q; Li H; Xie S; Xiao Q; Wang H; An Z
    Hum Vaccin Immunother; 2018 Apr; 14(4):894-899. PubMed ID: 29300680
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Reduced effectiveness of Haemophilus influenzae type b conjugate vaccine in children with a high prevalence of human immunodeficiency virus type 1 infection.
    Madhi SA; Petersen K; Khoosal M; Huebner RE; Mbelle N; Mothupi R; Saloojee H; Crewe-Brown H; Klugman KP
    Pediatr Infect Dis J; 2002 Apr; 21(4):315-21. PubMed ID: 12075763
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Haemophilus influenzae type b disease in HIV-infected children: a review of the disease epidemiology and effectiveness of Hib conjugate vaccines.
    Mangtani P; Mulholland K; Madhi SA; Edmond K; O'Loughlin R; Hajjeh R
    Vaccine; 2010 Feb; 28(7):1677-83. PubMed ID: 20034606
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Economisation of vaccination against Haemophilus influenzae type b: a randomised trial of immunogenicity of fractional-dose and two-dose regimens.
    Lagos R; Valenzuela MT; Levine OS; Losonsky GA; Erazo A; Wasserman SS; Levine MM
    Lancet; 1998 May; 351(9114):1472-6. PubMed ID: 9605803
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity and safety of four different doses of Haemophilus influenzae type b-tetanus toxoid conjugated vaccine, combined with diphtheria-tetanus-pertussis vaccine (DTP-Hib), in Indonesian infants.
    Punjabi NH; Richie EL; Simanjuntak CH; Harjanto SJ; Wangsasaputra F; Arjoso S; Rofiq A; Prijanto M; Julitasari ; Yela U; Herzog C; Cryz SJ
    Vaccine; 2006 Mar; 24(11):1776-85. PubMed ID: 16303216
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.